title: Tungsten carbide-cobalt as a nanoparticulate reference positive control in in vitro genotoxicity assays.
abstract: With the increasing human exposure to nanoparticles (NP), the evaluation of their genotoxic potential is of significant importance. However, relevance for NP of the routinely used in vitro genotoxicity assays is often questioned, and a nanoparticulate reference positive control would therefore constitute an important step to a better testing of NP, ensuring that test systems are really appropriate. In this study, we investigated the possibility of using tungsten carbide-cobalt (WC-Co) NP as reference positive control in in vitro genotoxicity assays, including 2 regulatory assays, the mouse lymphoma assay and the micronucleus assay, and in the Comet assay, recommended for the toxicological evaluation of nanomedicines by the French Agency of Human Health Products (Afssaps). Through these assays, we were able to study different genetic endpoints in 2 cell types commonly used in regulatory genotoxicity assays: the L5178Y mouse lymphoma cell line and primary cultures of human lymphocytes. Our results showed that the use of WC-Co NP as positive control in in vitro genotoxicity assays was conceivable, but that different parameters have to be considered, such as cell type and treatment schedule. L5178Y mouse lymphoma cells did not provide satisfactory results in the 3 performed tests. However, human lymphocytes were more sensitive to genotoxic effects induced by WC-Co NP, particularly after a 24-h treatment in the in vitro micronucleus assay and after a 4-h treatment in the in vitro Comet assay. Under such conditions, WC-Co could be used as a nanoparticulate reference positive control in these assays.
authors.affiliation: * Institut Pasteur de Lille, 59019 Lille Cedex, France;
authors.forename: Hélène
authors.initials: H
authors.lastname: Moche
authors.forename: Dany
authors.initials: D
authors.lastname: Chevalier
authors.forename: Nicolas
authors.initials: N
authors.lastname: Barois
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Lorge
authors.forename: Nancy
authors.initials: N
authors.lastname: Claude
authors.forename: Fabrice
authors.initials: F
authors.lastname: Nesslany
mesh_terms: D000328:Adult; D000818:Animals; D045744:Cell Line, Tumor; D003035:Cobalt / Q000633:toxicity*; D020552:Comet Assay / Q000592:standards; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008223:Lymphoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008297:Male; D053768:Metal Nanoparticles / Q000633:toxicity*; D051379:Mice; D048629:Micronuclei, Chromosome-Defective / Q000139:chemically induced; D015162:Micronucleus Tests / Q000592:standards; D009152:Mutagenicity Tests / Q000592:standards*; D012015:Reference Standards; D017973:Tungsten Compounds / Q000633:toxicity*
chemical_list: D017973:Tungsten Compounds; C002802:tungsten carbide; D003035:Cobalt
keywords: comet assay; micronucleus assay; mouse lymphoma assay; nanoparticle; regulatory test.